Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
308.67
146.80
164.09
175.24
305.12
105.16
197.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
308.67
146.80
164.09
175.24
305.12
105.16
197.73
Raw Material Cost
116.10
96.69
82.97
85.26
122.73
76.40
95.04
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.83
2.47
2.06
1.86
1.70
2.13
1.97
Selling and Distribution Expenses
35.94
34.78
21.40
17.95
32.01
38.64
26.71
Other Expenses
2.79
8.00
1.94
2.42
2.46
3.27
2.01
Total Expenditure (Excl Depreciation)
182.80
213.94
125.85
129.26
181.06
149.87
143.79
Operating Profit (PBDIT) excl Other Income
125.9
-67.1
38.199999999999996
46
124.1
-44.699999999999996
53.9
Other Income
-11.58
-3.29
4.63
19.49
13.56
33.68
2.82
Operating Profit (PBDIT)
113.19
-72.79
60.87
77.51
155.07
-7.97
71.39
Interest
2.83
2.47
2.06
1.86
1.70
2.13
1.97
Exceptional Items
-3.04
-0.54
-0.50
-0.26
0.81
5.25
0.53
Gross Profit (PBDT)
192.58
50.11
81.12
89.98
182.39
28.77
102.70
Depreciation
0.00
19.65
19.65
17.45
17.45
16.24
16.24
Profit Before Tax
107.33
-95.44
38.67
57.94
136.73
-21.08
53.71
Tax
10.67
-18.98
0.98
7.80
17.53
1.12
4.56
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
96.66
-76.46
37.69
50.15
119.20
-22.19
49.15
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
96.66
-76.46
37.69
50.15
119.20
-22.19
49.15
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
96.66
-76.46
37.69
50.15
119.20
-22.19
49.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,367.19
2,269.36
2,347.30
2,425.71
2,371.77
2,271.89
2,294.06
Earnings per share (EPS)
0.12
-0.09
0.05
0.06
0.14
-0.03
0.06
Diluted Earnings per share
0.12
-0.09
0.05
0.06
0.14
-0.03
0.06
Operating Profit Margin (Excl OI)
40.42%
-60.73%
22.3%
23.15%
40.66%
-55.05%
26.47%
Gross Profit Margin
34.77%
-51.63%
35.54%
43.02%
50.53%
-4.6%
35.38%
PAT Margin
31.32%
-52.09%
22.97%
28.62%
39.07%
-21.11%
24.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 110.29% vs -10.54% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 226.41% vs -302.92% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 279.57% vs -223.67% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 12.00% vs 19.05% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
Compare Quarterly Results Of Zhejiang Ausun Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
308.67
0
308.67
Other Operating Income
0.00
0.00
0.00
Total Operating income
308.67
0
308.67
Raw Material Cost
116.10
0
116.10
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.83
0
2.83
Selling and Distribution Expenses
35.94
0
35.94
Other Expenses
2.79
0.00
2.79
Total Expenditure (Excl Depreciation)
182.80
0
182.80
Operating Profit (PBDIT) excl Other Income
125.87
0.00
125.87
Other Income
-11.58
0
-11.58
Operating Profit (PBDIT)
113.19
0
113.19
Interest
2.83
0
2.83
Exceptional Items
-3.04
0
-3.04
Gross Profit (PBDT)
192.58
0
192.58
Depreciation
0.00
0
0.00
Profit Before Tax
107.33
0
107.33
Tax
10.67
0
10.67
Provisions and contingencies
0
0
0.00
Profit After Tax
96.66
0
96.66
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
96.66
0
96.66
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
96.66
0
96.66
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,367.19
0
2,367.19
Earnings per share (EPS)
0.12
0
0.12
Diluted Earnings per share
0.12
0
0.12
Operating Profit Margin (Excl OI)
40.42%
0%
0.00
40.42%
Gross Profit Margin
34.77%
0%
0.00
34.77%
PAT Margin
31.32%
0%
0.00
31.32%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 30.87 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 110.29% vs -10.54% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 1.18% vs 1.40% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 9.67 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 226.41% vs -302.92% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -18.88% vs 5.96% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.48 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 279.57% vs -223.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -11.80% vs 4.27% in Mar 2025
Quarterly - Interest
Interest 0.28 Million
in Mar 2026Figures in Million
QoQ Growth in quarter ended Mar 2026 is 12.00% vs 19.05% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 64.71% vs 0.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 40.42%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
